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Although a role for the airway circulation in
the clearance of inhaled particles is generally
assumed, there is little information to con-
firm its importance (1,2). The subject has
broad interest when considering particle dis-
persion for soluble species (therapeutic and
harmful as well, e.g., antigenic) that deposit
onto the delicate epithelial surfaces of the
conducting airways. Recently, the importance
of the circulation for the maintenance of nor-
mal mucociliary transport has been reported
(3). Although the primary clearance pathways
for insoluble and soluble particles differ
(mucociliary transport vs intravascular
absorption), it is likely that both rely heavily
on the extent of airway perfusion. The
bronchial artery perfuses the airways from the
level of the carina to the terminal bronchioles,
supplying the mucosal plexus as well as the
parallel adventitial plexus located external to
the airway smooth muscle (4). The mucosal
capillary plexus, located in the subepithelial
space, provides systemic access for all soluble
substances that are deposited on the airway
surface and that traverse the bronchial epithe-
lium. Thus, selective alteration of the perfu-
sion of mucosal capillaries underlying the
epithelial basement membrane may affect the
efficiency of particle uptake. Decreases in
bronchial blood flow due to systemic
hypotension, left atrial hypertension,
increased airway pressure/lung volume, or
lung transplantation could alter particle
uptake of therapeutic as well as toxicologic
aerosols deposited on the airway surface.
Little experimental information is available
regarding soluble particle uptake into the vas-
culature of the conducting airways. After
infusing the soluble hydrophilic tracer
technetium-99m–labeled diethylenetriamine
pentaacetic acid (99mTc-DTPA ) into an iso-
lated sheep tracheal segment, Hanaﬁ and col-
leagues reported the appearance of the tracer in
a cannulated tracheal vein (5). Paradoxically,
in their in situ preparation, tracer uptake into
the circulation was shown to be inversely
related to the level of tracheal blood ﬂow. In
the present study, we hypothesized that
removal of soluble particles deposited onto an
intrathoracic, subcarinal airway would be
dependent on bronchial blood ﬂow. We pro-
posed that decreasing bronchial perfusion
would decrease vascular absorption of a solu-
ble tracer applied to the airway surface. We
tested this hypothesis in vivo by limiting the
blood supply to the airways and measuring
the kinetics of soluble particle clearance.
Materials and Methods
The study protocol was approved by The
Johns Hopkins Animal Care and Use
Committee. Anesthesia was induced in sheep
(25–35 kg) with intramuscular ketamine (30
mg/kg) and subsequently maintained with
intravenous pentobarbital sodium (20
mg/kg/hr). The sheep were positioned supine
on a surgical table, and after a tracheotomy
was performed, the animals were intubated
and paralyzed with pancuronium bromide
(2 mg intravenously). The lungs were
mechanically ventilated with a tidal volume
of 10–12 mL/kg at a rate (12–15 breaths/
min) sufficient to maintain normal blood
gases. Positive end-expiratory pressure (5
cm H2O) was applied. The left thorax was
opened at the fifth intercostal space, and
heparin (20,000 U intravenously) was
administered. The esophageal and thoracic
tracheal branches of the bronchoesophageal
artery were ligated as previously described
(6). The bronchial branch of the bronchoe-
sophageal artery was isolated, cannulated,
and perfused (0.6 mL/min/kg) with autolo-
gous blood withdrawn from the descending
aorta and pumped through a variable-speed
roller pump (7,8).
Local Tracer Delivery
The small (492 daltons), soluble, hydrophilic
tracer 99mTc-DTPA was used to assess clear-
ance from the airways and uptake by the
bronchial circulation. DTPA was freshly pre-
pared on each experiment day as 99mTc-
labeled DTPA (Medi-Physics, Arlington
Heights, IL, USA). Local airway delivery was
performed to ensure deposition of the tracer
exclusively onto surfaces of conducting air-
ways perfused by the bronchial circulation. A
fiberoptic bronchoscope (5 mm OD,
Olympus Corp., Lake Success, NY, USA)
was advanced through the trachea beyond
the carina and into a fourth generation
bronchus. A polyethylene catheter with a
microspray nozzle at the tip was advanced
through the working channel of the bron-
choscope and visualized beyond the end of
the bronchoscope (9). After momentarily
stopping ventilation, 6–10 µL 99mTc-DTPA,
which had been loaded into the catheter tip,
was sprayed radially onto the airway wall.
The catheter was then retracted into the
channel of the bronchoscope, and the bron-
choscope was removed from the animal.
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Controlled ventilation resumed, and serial
dynamic images of clearance of the 99mTc-
DTPA were acquired every 2 min for 30 min
using NucLear MAC (Scientific Imaging,
Inc., Littleton, CO, USA) and a gamma
camera (MaxiCamera, General Electric,
Waukesha, WI, USA). Radioisotope delivery
and clearance data were quantitated with
techniques modified from Foster and
Stetkiewicz (10). The initial bronchial image
acquired immediately after delivery of the
99mTc-DTPA was stored on a video screen
and this enabled a region of interest to be
selected by cursor manipulation and drawn
to cover the site of 99mTc-DTPA delivery.
For the clearance of 99mTc-DTPA, activity
time plots were constructed for the region of
interest. The retention of radioactivity dur-
ing the 30-min washout was corrected for
radioactive decay and expressed as a percent-
age of the 99mTc-DTPA delivered to the
region at time 0 (immediately after the noz-
zle catheter and bronchoscope were with-
drawn from the bronchial airway). The
average retention time was calculated as ∑
activity × time/∑ activity.
Blood Uptake
To determine blood uptake of tracer, we
acquired systemic venous blood samples (0.5
mL) every 6 min for the 30-min period.
Activity in blood was counted in a gamma
counter (GammaTrac, TmAnalytic, Tampa,
FL). To estimate the total amount of radiola-
bel in the blood of the sheep, we calculated
the nominal blood volume equal to 8.5%
body weight (11). We estimated total blood
99mTc-DTPA by multiplying counts per
minute per milliliter by total blood volume;
results are presented as a fraction of the total
delivered 99mTc-DTPA.
Protocols
Airway clearance and blood uptake of 99mTc-
DTPA were measured in sheep during control
bronchial artery perfusion and when bronchial
perfusion was stopped by turning off the per-
fusion pump. Blood flow was altered 5 min
prior to the delivery of 99mTc-DTPA. To
eliminate issues of attenuation of radioactivity
due to regional differences in airway geometry
and the subsequent two-dimensional image
acquisition, we performed all evaluations
(control vs no ﬂow) as paired comparisons in
the same airways. Thus, the experimental
design of the protocol was to use each animal
preparation as its own control, obtain mea-
surements of 99mTc-DTPA, clearance during
control ﬂow conditions, followed by redeliv-
ery of 99mTc-DTPA and measure clearance
during no-ﬂow conditions. Bronchoscopy was
performed by mapping into a speciﬁc fourth
generation bronchus for the control flow
deposition. The subsequent deposition during
the interruption of bronchial blood ﬂow took
place in the same location.
Statistics
All data are presented as mean values ±
standard errors. The Wilcoxon signed ranks
test was used to determine differences
between the two bronchial blood-ﬂow condi-
tions. p < 0.05 was accepted as signiﬁcant.
Results
We studied seven sheep (29 ± 3 kg body
weight) in which control bronchial blood
ﬂow averaged 18 ± 2 mL/min and resulted in
a bronchial artery perfusion pressure of 86 ±
8 mmHg. Systemic arterial pressure averaged
93 ± 2 mmHg and peak inspiratory pressure
was 17 ± 2 cm H2O. Figure 1 shows a
representative experiment, documenting
the method for measuring 99mTc-DTPA
clearance from the deposition site.
Additionally, as the radioactive tracer was
observed to move progressively up the airway
tree (cranially), the series demonstrates that
much of the label was removed from the
deposition site by mucociliary clearance. This
was a consistent observation among all the
animals studied. The actual retained activity
as a function of that originally deposited
(100%) for three time points is shown in
Figure 2. Within 30 min most of the 99mTc-
DTPA was cleared from the deposition site.
At 30 min an average of 21.1 ± 5.4% of the
deposited label remained within the airway
site. The average retention time for 99mTc-
DTPA clearance was 10.5 ± 1.1 min. When
the bronchial perfusion pump was turned off
(no ﬂow) prior to the second airway deposi-
tion, 99mTc-DTPA retention increased. The
activity retained during no flow and at the
same deposition site is also presented in
Figure 2. Retained activity at 30 min was
42.6 ± 10.9% (p = 0.03 compared to control
flow). Average retention time also increased
to 13.3 ± 0.6 min (p = 0.03 compared to con-
trol flow). To further characterize the clear-
ance pathways, bronchial vascular absorption
was estimated by measuring the amount of
radiolabel in systemic blood samples every 6
min throughout the 30-min time course. The
total 99mTc-DTPA present in blood was
extrapolated from the measured amount in a
0.5-mL venous blood sample and the total
blood volume of the sheep [estimated as
8.5% of body mass in kilograms; (11)]. Thus,
99mTc-DTPA activity in the blood could be
calculated as a fraction of the total delivered
to the animal. A comparison of average blood
activity during control ﬂow and no-ﬂow con-
ditions is shown in Figure 3. The time to
maximum blood activity was 12–18 min in
the three animals during control ﬂow condi-
tions. The maximum values during control
flow and their corresponding values at the
Figure 1. Serial gamma camera images of 99mTc-DTPA in airways in one sheep. 99mTc-DTPA image (white spot)
deposited in a subcarinal airway appears to move to the right (cranially) over the course of 15 frames (30 min).
Figure 2. Time course of clearance of 99mTc-DTPA from
subcarinal airway during control flow and when
bronchial artery perfusion is interrupted (no flow).
Average (± SE) radioactivity retained at the site of depo-
sition in seven sheep at three time points.
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same time during no-flow conditions are as
follows: 18.4 versus 4.2%, 10.2 versus 6.8%,
and 10.7 versus 6.6%. In each experiment
99mTc-DTPA activity absorbed into blood
during no-flow conditions was considerably
less than during control flow conditions.
However, it should be noted that the maxi-
mum activity in the blood at any time point
was always less than 20% of the delivered
label. Furthermore, during control conditions
approximately 80% of 99mTc-DTPA
deposited onto the airway wall of a conduct-
ing airway was removed from the deposition
site. During the no-ﬂow conditions less than
10% was absorbed into the blood and
approximately 60% was removed from the
deposition site. Thus, a signiﬁcant fraction of
the 99mTc-DTPA likely was cleared by
mucociliary function, as observed in Figure 1.
Discussion
The results of this study in anesthetized sheep
demonstrate the importance of the bronchial
circulation in the clearance of small, soluble
substances deposited onto the subcarinal air-
ways. Interrupting bronchial artery perfusion
resulted in both an increased retention of sol-
uble tracer at the site of deposition and an
attenuation in the uptake of 99mTc-DTPA
into the systemic blood. Additionally, during
both ﬂow conditions, much of the delivered
tracer could not be accounted for by the com-
bined activity at the site of deposition and the
maximum levels in the blood. Although clear-
ance from the blood by the kidneys might
contribute, the amount of label that needed
to be accounted for was too high to be
removed exclusively by excretion (12).
Furthermore, serial images of the conducting
airways demonstrated that a significant frac-
tion of the deposited label appeared to move
by mucociliary action. Thus, the two major
observations of this series of experiments were
the bronchial blood ﬂow dependence of solu-
ble tracer kinetics and mucociliary clearance
of a soluble substance deposited in the
conducting airways. 
The mechanisms responsible for the
blood flow dependence of soluble tracer
kinetics are related to both a decrease in the
blood uptake of the soluble tracer and a pre-
sumed decrease in mucociliary clearance of
the tracer. Blood uptake was only attenuated
and not completely absent when blood ﬂow
was interrupted. This result is likely related
to two factors. First, interruption of perfu-
sion does not prevent collateral flow at
downstream sites. Baile et al., using aggres-
sive methods to obliterate the bronchial vas-
culature, demonstrated a persistent, albeit
greatly decreased, perfusion to the precapil-
lary vessels, even after occluding the main
bronchial arterial inflow in sheep (13).
Additionally, as mucociliary activity was pre-
sent during both flow conditions, delivered
99mTc-DTPA did not remain exclusively at
the site of deposition. At later time points
when tracer was in transit through the tra-
cheal airway, uptake by blood vessels in the
trachea where blood ﬂow was not controlled
likely contributed to the total systemic
venous 99mTc-DTPA activity. Thus exami-
nation of the blood activity during early
time points more accurately reflects blood
uptake in the subcarinal airways before the
mucociliary transport of surface activity into
the tracheal airway. 
We have previously reported the depen-
dence of mucociliary clearance on bronchial
perfusion (3). Decreased bronchial artery
perfusion resulted in a signiﬁcant slowing of
the mucociliary clearance of the inert, insol-
uble tracer, 99mTc-sulfur colloid deposited
in the conducting airways. We speculated
that the mechanism for the reduction in par-
ticle clearance relates to the changes in cells
or structures dependent on normal
bronchial blood flow. Changes in nutrient
flow, wall temperature and/or humidity,
shear-induced mediator release, or ischemic
injury might all account for this observation.
Thus, in the present study it is presumed
that impaired mucociliary function as well as
decreased blood uptake contributed to the
increased retention of 99mTc- DTPA at the
deposition site.
Our results, however, are inconsistent
with previous observations reported by
Hanafi et al., who examined soluble tracer
kinetics in an isolated tracheal segment (5).
Using an in vivo sheep preparation, these
investigators filled an isolated tracheal seg-
ment with 99mTc-DTPA in a physiologic salt
solution and then measured tracheal artery
and venous blood flow. Thus, the experi-
mental preparation eliminated the mucocil-
iary component as a potential pathway of
clearance. These investigators showed that
decreasing perfusion resulted in an increase in
the venous uptake and clearance of the tracer.
They suggested that decreased perfusion
resulted in a decrease in interstitial ﬂuid vol-
ume of the airway wall, which might decrease
the barrier to tracer uptake into the vascula-
ture. Another potential explanation provided
was related to the fact that in their experi-
mental setup, arterial inﬂow was never equal
to the venous outﬂow of the isolated segment.
Thus, perfusion redistribution through collat-
eral vascular channels might have been altered
with changes in inflow, obscuring the true
changes in tracer concentrations. 
In summary, as a ﬁrst step toward deﬁning
the preferential clearance pathways of soluble
particles deposited onto intrathoracic airways,
we have shown in vivo that bronchial blood
ﬂow is essential for absorption and redistribu-
tion of the particles, and their clearance along
the airway surface. Aqueous particles were
removed from the subcarinal surface by two
dynamic processes: a) dispersion into the
subepithelial vascular network lining the air-
ways and transferred to the systemic blood
pool, and b) transport along with respiratory
mucus by mucociliary clearance into the tra-
cheal airway. The effectiveness of both of
these processes is impaired when bronchial
perfusion becomes limited. 
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Figure 3. Average (± SE) 99mTc-DTPA activity in blood as
percent of total delivered to the airway at three time
points. n = 3 sheep.
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